JP2000072728A - Production of optically active alpha-substituted-beta- aminoketone derivative - Google Patents

Production of optically active alpha-substituted-beta- aminoketone derivative

Info

Publication number
JP2000072728A
JP2000072728A JP10238064A JP23806498A JP2000072728A JP 2000072728 A JP2000072728 A JP 2000072728A JP 10238064 A JP10238064 A JP 10238064A JP 23806498 A JP23806498 A JP 23806498A JP 2000072728 A JP2000072728 A JP 2000072728A
Authority
JP
Japan
Prior art keywords
group
formula
lower alkyl
general formula
optically active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP10238064A
Other languages
Japanese (ja)
Inventor
Shingo Yamazaki
新五 山崎
Takehiko Iida
剛彦 飯田
Takayoshi Arai
孝義 荒井
Masakatsu Shibazaki
正勝 柴崎
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsui Chemicals Inc
Original Assignee
Mitsui Chemicals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsui Chemicals Inc filed Critical Mitsui Chemicals Inc
Priority to JP10238064A priority Critical patent/JP2000072728A/en
Publication of JP2000072728A publication Critical patent/JP2000072728A/en
Pending legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/52Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts

Landscapes

  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

PROBLEM TO BE SOLVED: To directly produce an optically active α-substituted-β-aminoketone derivative from an optically inactive starting raw material by carrying out asymmetric Mannich reaction using a specific comples, a Lewis acid and a specific derivative. SOLUTION: (A) A synthetic zeolite, (B) a ketone and (C) an optically active aluminum-alkali metal-binaphthol complex of formula I, etc., are stirred and mixed in a solvent under an inert gas atmosphere and the mixture is reacted with (D) a Lewis acid of formula II (M is lanthanum, ytterbium or scandium; (m) is a positive number) and an α-aminoether derivative of formula III [R1 is a lower alkyl, phenyl or benzyl; R2 and R3 are each an (un)saturated lower alkyl or the like] to obtain the objective derivative of formula IV [R4 is a group of formula V (R7 is trifluoromethyl or a lower alkyl) or the like] having asymmetric structure induced at the α-position of the component B. The derivative has central muscle relaxing action.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、中枢性の筋弛緩作
用を有する光学活性α−置換−β−アミノケトン誘導体
の製造方法に関し、この誘導体を多機能複合金属錯体を
用いた触媒的不斉合成により製造する方法に関する。
TECHNICAL FIELD The present invention relates to a method for producing an optically active α-substituted-β-aminoketone derivative having a central muscle relaxing action, and to asymmetric catalytic synthesis of this derivative using a multifunctional complex metal complex. And a method for producing the same.

【0002】[0002]

【従来の技術】中枢性筋弛緩作用を有する光学活性α−
置換−β−アミノケトン誘導体の製造法としてラセミ体
の光学分割法が知られている。例えば、特開平1−13
1171号公報には、アセチルフェニルグリシン又はリ
ンゴ酸を光学分割剤として用いた光学活性2−メチル−
1−(4−トリフルオロメチルフェニル)−5−ピロリ
ジノ−1−プロパノンの製造法が開示されている。ま
た、特開平8−208572号公報には、カンファース
ルホン酸を光学分割剤として、所望の光学異性体を得た
後、不要な異性体をラセミ化回収することを特徴とする
光学活性3−フェニル−5−{2−(ピロリジニルメチ
ル)ブチリル}イソオキサゾールの製造法が示されてい
る。
2. Description of the Related Art Optically active α- having a central muscle relaxing action
As a method for producing a substituted-β-aminoketone derivative, a racemic optical resolution method is known. For example, JP-A-1-13
No. 1171 discloses an optically active 2-methyl-methyl ester using acetylphenylglycine or malic acid as an optical resolving agent.
A method for producing 1- (4-trifluoromethylphenyl) -5-pyrrolidino-1-propanone is disclosed. Japanese Patent Application Laid-Open No. 8-208572 discloses an optically active 3-phenyl wherein after using camphorsulfonic acid as an optical resolving agent, a desired optical isomer is obtained and the unnecessary isomer is recovered by racemization. A method for producing -5- {2- (pyrrolidinylmethyl) butyryl} isoxazole is shown.

【0003】しかしながら、これらの方法では所望の光
学異性体を得ると同時に不要な光学異性体をも同時に等
量製造するので、産業廃棄物の増大等に関して環境への
負荷が問題視されている昨今、必ずしも優れた方法とは
言い難い。特開平8−208572号公報の例では不要
な光学異性体をラセミ化回収することにより前記の問題
の解決を図っているが、回収工程の追加によって製造設
備が増大化する等、工業的製造法として未だ十分に優れ
ているとも言い難く、触媒的不斉合成法の開発が望まれ
ていた。
However, in these methods, a desired optical isomer is obtained and an unnecessary optical isomer is simultaneously produced in an equal amount. However, it is not always an excellent method. In the example of Japanese Patent Application Laid-Open No. 8-208572, the above-mentioned problem is solved by recovering unnecessary optical isomers by racemization. However, the production process is increased by adding a recovery step. Therefore, it is difficult to say that the method is still sufficiently excellent, and it has been desired to develop a catalytic asymmetric synthesis method.

【0004】[0004]

【発明が解決しようとする課題】本発明の課題は、前述
した光学分割法によることなく、多機能複合金属錯体で
ある光学活性アルミニウム−アルカリ金属−ビナフトー
ル錯体を触媒として使用し、同時にルイス酸を共存さ
せ、α−アミノエーテル誘導体を用いた不斉マンニッヒ
反応により、光学不活性な出発原料より光学活性α−置
換−β−アミノケトン誘導体を直接的に製造する方法を
提供することである。
The object of the present invention is to use an optically active aluminum-alkali metal-binaphthol complex, which is a multifunctional complex metal complex, as a catalyst without using the above-mentioned optical resolution method, and at the same time to use Lewis acid. An object of the present invention is to provide a method for directly producing an optically active α-substituted-β-aminoketone derivative from an optically inactive starting material by coexistence and an asymmetric Mannich reaction using an α-aminoether derivative.

【0005】[0005]

【課題を解決する為の手段】本発明者らは、光学活性ア
ルミニウム−アルカリ金属−ビナフトール錯体等を含む
多機能複合金属錯体を開発し、このものを触媒とした、
不斉アルドール反応、不斉ハイドロホスホニル化反応、
不斉ディールズ=アルダー反応、不斉マイケル反応等に
おける有用性を報告してきた(アンゲバンテ ケミー
インターナショナル エディション イン イングリッ
シュ、第36巻、1236ページ、1997年)。前述
のα−置換−β−アミノケトン誘導体は一般的にはケト
ン類、ホルムアルデヒド類及び2級アミン類を出発原料
としたマンニッヒ反応で製造できるが、本発明者らはケ
トン類、α−アミノエーテル誘導体の反応系に光学活性
アルミニウム−アルカリ金属−ビナフトール錯体及びル
イス酸を触媒量添加することにより、ケトン類のα位に
不斉が誘起された光学活性α−置換−β−アミノケトン
誘導体が生成することを見出し、本発明を完成するに至
った。
Means for Solving the Problems The present inventors have developed a multifunctional complex metal complex containing an optically active aluminum-alkali metal-binaphthol complex and the like, and used this as a catalyst.
Asymmetric aldol reaction, asymmetric hydrophosphonylation reaction,
It has been reported usefulness in asymmetric Diels-Alder reaction, asymmetric Michael reaction, etc. (Angevante Chemie
International Edition in English, Vol. 36, p. 1236, 1997). The above-mentioned α-substituted-β-aminoketone derivatives can be generally produced by a Mannich reaction using ketones, formaldehydes and secondary amines as starting materials. The addition of a catalytic amount of an optically active aluminum-alkali metal-binaphthol complex and a Lewis acid to the reaction system to produce an optically active α-substituted-β-aminoketone derivative in which asymmetry is induced at the α-position of ketones. And completed the present invention.

【0006】即ち、本発明は光学活性アルミニウム−ア
ルカリ金属−ビナフトール錯体、ルイス酸及びα−アミ
ノエーテル誘導体を用いて不斉マンニッヒ反応を行う、
光学活性α−置換−β−アミノケトン誘導体の製造方法
であり、且つ前記光学活性アルミニウム−アルカリ金属
−ビナフトール錯体が一般式(1)〔一般式(1−1)
及び(1−2)〕
That is, the present invention provides an asymmetric Mannich reaction using an optically active aluminum-alkali metal-binaphthol complex, a Lewis acid and an α-aminoether derivative.
A method for producing an optically active α-substituted-β-aminoketone derivative, wherein the optically active aluminum-alkali metal-binaphthol complex is represented by the general formula (1) [General formula (1-1)
And (1-2)]

【化8】 で表される化合物である光学活性α−置換−β−アミノ
ケトン誘導体の製造方法であり、
Embedded image A method for producing an optically active α-substituted-β-aminoketone derivative, which is a compound represented by

【0007】またルイス酸が一般式(2)The Lewis acid has the general formula (2)

【化9】 (式中、Mはランタン原子、イッテルビウム原子または
スカンジウム原子を、mは正の数を表す)で表される化
合物である光学活性α−置換−β−アミノケトン誘導体
の製造方法であり、
Embedded image Wherein M represents a lanthanum atom, a ytterbium atom or a scandium atom, and m represents a positive number, and is a method for producing an optically active α-substituted-β-aminoketone derivative,

【0008】更に、α−アミノエーテル誘導体が一般式
(3)
Further, the α-amino ether derivative has the general formula (3)

【化10】 〔式中、R1は低級アルキル基、フェニル基またはベン
ジル基、R2及びR3は独立に飽和もしくは不飽和の低
級アルキル基を表すか、R2とR3がひとつになって一
般式(4)
Embedded image [Wherein, R1 represents a lower alkyl group, a phenyl group or a benzyl group, R2 and R3 independently represent a saturated or unsaturated lower alkyl group, or R2 and R3 become one to form a general formula (4)

【化11】 (式中、nは0または1〜2の整数を表し、Zは酸素原
子、メチレン基、アミノ基、メチルアミノ基、ベンジル
アミノ基を表す。)を表す。〕である光学活性α−置換
−β−アミノケトン誘導体の製造方法であり、
Embedded image (In the formula, n represents 0 or an integer of 1 to 2, and Z represents an oxygen atom, a methylene group, an amino group, a methylamino group, or a benzylamino group.) A method for producing an optically active α-substituted-β-aminoketone derivative

【0009】光学活性α−置換−β−アミノケトン誘導
体が、一般式(5)
The optically active α-substituted-β-aminoketone derivative has the general formula (5)

【化12】 〔式中、R4は、一般式(6)〔一般式(6−1)及び
(6−2)〕
Embedded image [In the formula, R4 is the general formula (6) [the general formulas (6-1) and (6-2)]

【化13】 (R6はハロゲン原子;低級アルキル基;ベンジル基;
ベンゾイル基;ピリジル基;低級アルキル基で置換され
てもよいフリル基;低級アルキル基で置換されてもよい
チエニル基;ハロゲン原子、低級アルコキシ基、トリフ
ルオロメチル基、シアノ基、ニトロ基、アミノ基、ジメ
チルアミノ基、アセトアミド基、メタンスルホニルアミ
ド基、アセチル基または低級アルコキシカルボニル基で
置換されていてもよいフェニル基;またはナフチル基
を、R7はトリフルオロメチル基、低級アルキル基を、
Yは酸素原子または硫黄原子を表す)で表され、R2は
低級アルキル基;ベンジル基;メトキシ基;フェニル
基;アリル基;トリフルオロメチル基または低級アルコ
キシ基で置換されたアルキル基;またはシクロプロピル
メチル基を、R3及びR4は独立に飽和もしくは不飽和
の低級アルキル基を表し、R3とR4がひとつになって
一般式(4)
Embedded image (R6 is a halogen atom; a lower alkyl group; a benzyl group;
Benzoyl group; pyridyl group; furyl group optionally substituted by lower alkyl group; thienyl group optionally substituted by lower alkyl group; halogen atom, lower alkoxy group, trifluoromethyl group, cyano group, nitro group, amino group A phenyl group which may be substituted with a dimethylamino group, an acetamido group, a methanesulfonylamido group, an acetyl group or a lower alkoxycarbonyl group; or a naphthyl group; R7 represents a trifluoromethyl group or a lower alkyl group;
Y represents an oxygen atom or a sulfur atom), and R2 is a lower alkyl group; a benzyl group; a methoxy group; a phenyl group; an allyl group; an alkyl group substituted with a trifluoromethyl group or a lower alkoxy group; R3 and R4 each independently represent a saturated or unsaturated lower alkyl group, and R3 and R4 become one to form a general formula (4)

【化14】 (式中、nは0または1〜2の整数を表し、Zは、酸素
原子、メチレン基、アミノ基、メチルアミノ基、ベンジ
ルアミノ基を表す。)を表す。}で表される光学活性α
−置換−β−アミノケトン誘導体の製造方法である。
Embedded image (In the formula, n represents 0 or an integer of 1 to 2, and Z represents an oxygen atom, a methylene group, an amino group, a methylamino group, or a benzylamino group.) Optical activity α represented by}
A method for producing a substituted-β-aminoketone derivative.

【0010】本発明の具体的な様態は以下の通りであ
る。すなわち、アルゴン、窒素等の不活性ガス雰囲気
下、反応溶媒として、石油エーテル、n−ヘキサン、ペ
プタン、シクロヘキサン等の脂肪族炭化水素系、ベンゼ
ン、トルエン、キシレン等の芳香族炭化水素系、ジクロ
ロメタン、クロロホルム、四塩化炭素等のハロゲン系、
酢酸エチル−酢酸n−ブチル等のエステル系、ジエチル
エーテル、ジイソプロピルエーテル、テトラヒドロフラ
ン、1,4−ジオキサン、ジグライム等のエーテル系溶
媒及びそれら2種以上の混合溶媒を用い、合成ゼオライ
ト、
The specific embodiments of the present invention are as follows. That is, under an inert gas atmosphere such as argon and nitrogen, as a reaction solvent, petroleum ether, n-hexane, peptane, aliphatic hydrocarbons such as cyclohexane, benzene, toluene, aromatic hydrocarbons such as xylene, dichloromethane, Halogen such as chloroform and carbon tetrachloride,
Using an ester solvent such as ethyl acetate-n-butyl acetate, diethyl ether, diisopropyl ether, tetrahydrofuran, 1,4-dioxane, an ether solvent such as diglyme and a mixed solvent of two or more thereof, synthetic zeolite,

【0011】一般式(7)〔一般式(7−1)及び(7
−2)〕
The general formula (7) [General formulas (7-1) and (7)
-2)]

【化15】 (式中、R2、R5、R6及びYは前記に同じ。)で表
されるケトン類及び、一般式(1)〔一般式(1−1)
及び(1−2)〕:
Embedded image (Wherein R2, R5, R6 and Y are the same as described above), and a general formula (1) [general formula (1-1)
And (1-2)]:

【化16】 (式中、Xは前記に同じ。)で表される光学活性アルミ
ニウム−アルカリ金属−ビナフトール錯体を混合攪拌
し、
Embedded image (Wherein X is the same as described above), and mixed and stirred with an optically active aluminum-alkali metal-binaphthol complex represented by the following formula:

【0012】一般式(3)General formula (3)

【化17】 (式中、R1、R2及びR3は前記に同じ。)で表され
るα−アミノエーテル誘導体類、一般式(2)
Embedded image (Wherein R1, R2 and R3 are the same as described above) represented by the general formula (2):

【化18】 (式中、Mはランタン原子、イッテルビウム原子、スカ
ンジウム原子を、mは正の数を表す。)で表される化合
物であるルイス酸を加え、攪拌反応する。
Embedded image (In the formula, M represents a lanthanum atom, a ytterbium atom, or a scandium atom, and m represents a positive number.) A Lewis acid, which is a compound represented by the formula, is added, and the mixture is stirred and reacted.

【0013】反応の経過は、薄層クロマトグラフィー、
ガスクロマトグラフィー、高速液体クロマトグラフィー
等の分析手段で容易に追跡、確認することができる。反
応終了後の後処理は以下のようにして行なう。反応懸濁
液より合成ゼオライトを濾去し、希塩酸等の酸性水溶液
に転溶した後、水と非混和性の有機溶媒で洗浄する。そ
の後、目的物を含む水層をアンモニア水溶液等で中和
し、水と非混和性の有機溶媒で抽出し、硫酸マグネシウ
ム、硫酸ナトリウム等の脱水剤を用いて水分を除去後、
減圧下溶媒を溜去して得られる粗生成物を、結晶化、減
圧蒸留、カラムクロマトグラフィー(吸着剤としては、
市販のシリカゲル、アルミナ、フロリジル等が使用可能
である。)などによって精製し、目的物を得ることがで
きる。
The course of the reaction is determined by thin-layer chromatography,
It can be easily tracked and confirmed by analytical means such as gas chromatography and high performance liquid chromatography. Post-treatment after completion of the reaction is performed as follows. The synthetic zeolite is removed by filtration from the reaction suspension, and is dissolved in an acidic aqueous solution such as dilute hydrochloric acid, and then washed with an organic solvent immiscible with water. Thereafter, the aqueous layer containing the target substance is neutralized with an aqueous ammonia solution or the like, extracted with a water-immiscible organic solvent, and after removing water with a dehydrating agent such as magnesium sulfate and sodium sulfate,
The crude product obtained by distilling off the solvent under reduced pressure is crystallized, distilled under reduced pressure, and column chromatography (as the adsorbent,
Commercially available silica gel, alumina, florisil and the like can be used. ) To obtain the desired product.

【0014】また、粗生成物を塩酸、硫酸等の鉱酸、メ
タンスルホン酸、p−トルエンスルホン酸等のスルホン
酸などを用いて塩を形成し、結晶として単離精製する方
法も有効である。反応溶媒の使用量としては特に制限さ
れるものではないが、好ましくは一般式(7)で表され
るケトン類に対して、0〜100重量倍量である。より
好ましくは1〜20重量倍量である。
It is also effective to form a salt of the crude product using a mineral acid such as hydrochloric acid or sulfuric acid or a sulfonic acid such as methanesulfonic acid or p-toluenesulfonic acid and to isolate and purify the crystal as a crystal. . The amount of the reaction solvent used is not particularly limited, but is preferably 0 to 100 times the weight of the ketone represented by the general formula (7). More preferably, the amount is 1 to 20 times by weight.

【0015】合成ゼオライトとしては市販されているモ
レキュラーシーブ3A、モレキュラーシーブ4A、モレ
キュラーシーブ5A、モレキュラーシーブ10X、モレ
キュラーシーブ15X等が使用可能であるが、その中で
もモレキュラーシーブ3Aが好ましい。その使用量は特
に制限されるものではないが、通常は一般式(7)で表
されるケトン類に対して、5〜100重量倍量である。
より好ましくは10〜20重量倍量である。
As the synthetic zeolite, commercially available molecular sieves 3A, molecular sieves 4A, molecular sieves 5A, molecular sieves 10X, molecular sieves 15X and the like can be used, and among them, the molecular sieve 3A is preferable. The amount used is not particularly limited, but is usually 5 to 100 times the weight of the ketone represented by the general formula (7).
More preferably, the amount is 10 to 20 times by weight.

【0016】一般式(1)で表される光学活性アルミニ
ウム−アルカリ金属−ビナフトール錯体の使用量は、一
般式(7)で表されるケトン類に対して、0.01〜
0.2モル倍量が可能であるが、好ましくは0.05〜
0.1モル倍量である。一般式(2)で表されるルイス
酸の使用量は、一般式(7)で表されるケトン類に対し
て、0.01〜0.2モル倍量が可能であるが、好まし
くは0.05〜0.1モル倍量である。一般式(3)で
表されるα−アミノエーテル誘導体はジャーナル オブ
アメリカン ケミカル ソサイアティー、第53巻、
4172頁、1932年等の文献記載の方法で調製で
き、その使用量は一般式(7)で表されるケトン類に対
して、1〜10モル倍量が可能であるが、好ましくは1
〜2モル倍量である。反応温度は、−78℃〜使用溶媒
の沸点迄が可能であるが、反応収率及び、光学純度の面
より、−78℃〜+50℃が好ましい。より好ましくは
−40℃〜+25℃の温度範囲である。
The amount of the optically active aluminum-alkali metal-binaphthol complex represented by the general formula (1) is 0.01 to 0.01 with respect to the ketone represented by the general formula (7).
A 0.2 molar amount is possible, but preferably 0.05 to
It is 0.1 mole times. The amount of the Lewis acid represented by the general formula (2) can be 0.01 to 0.2 times the mol of the ketones represented by the general formula (7), but is preferably 0. It is 0.05 to 0.1 times by mole. The α-aminoether derivative represented by the general formula (3) is disclosed in Journal of American Chemical Society, Vol.
It can be prepared by the method described in the literature such as 4172 pages, 1932 and the like, and its use amount can be 1 to 10 times the molar amount of the ketone represented by the general formula (7).
22 molar times. The reaction temperature can be from −78 ° C. to the boiling point of the solvent used, but is preferably −78 ° C. to + 50 ° C. from the viewpoint of the reaction yield and the optical purity. More preferably, the temperature range is from -40C to + 25C.

【0017】[0017]

【実施例】次に本発明を実施例に基づいてさらに具体的
に説明するが、本発明はこれらの実施例によって何ら制
限されるものではない。光学純度 実施例における光学純度は順層系または逆層系の高速液
体カラムクロマトグラフィー分析で測定でき、式1の対
掌体過剰率(%ee)によって表される。 (式1): 対掌体過剰率={(目的物のピーク面積)−(対掌体の
ピーク面積)}×100÷{(目的物のピーク面積)+
(対掌体のピーク面積)}
EXAMPLES Next, the present invention will be described more specifically based on examples, but the present invention is not limited to these examples. Optical Purity The optical purity in the examples can be measured by high-performance liquid column chromatography analysis of a normal layer system or a reverse layer system, and is represented by the enantiomeric excess (% ee) of the formula 1. (Formula 1): enantiomeric excess = {(peak area of target) − (peak area of enantiomer)} × 100 {(peak area of target) +
(Peak area of antipod)}

【0018】参考例1 アルミニウム- リチウム−(R)−ビナフトール錯体
〔一般式(1−1)〕の調製(以下(R)−ALBと略
す。) アルゴン雰囲気下、水素化アルミニウムリチウム1.8
98g(50mmol)をテトラヒドロフラン200m
lに懸濁し、0℃にて(R)−(+)−1,1' −ビ−
2−ナフトール28.64g(100mmol)/テト
ラヒドロフラン300mlを30分かけて滴下した。0
℃にて30分攪拌した後、室温で1時間攪拌し、室温に
て終夜静置した上澄みを0.1M(R)−ALBのテト
ラヒドロフラン溶液として用いた。
Reference Example 1 Preparation of aluminum-lithium- (R) -binaphthol complex [general formula (1-1)] (hereinafter abbreviated as (R) -ALB) 1.8 lithium aluminum hydride in an argon atmosphere
98 g (50 mmol) of tetrahydrofuran 200 m
and (R)-(+)-1,1′-bi- at 0 ° C.
28.64 g (100 mmol) of 2-naphthol / 300 ml of tetrahydrofuran were added dropwise over 30 minutes. 0
After stirring at 30 ° C. for 30 minutes, the mixture was stirred at room temperature for 1 hour, and allowed to stand at room temperature overnight, and the supernatant was used as a 0.1 M (R) -ALB tetrahydrofuran solution.

【0019】参考例2 アルミニウム−リチウム−(S)−ビナフトール錯体
〔一般式(1−2)〕の調製(以下(S)−ALBと略
す。) 参考例1の操作において、(R)−(+)−1,1' −
ビ−2−ナフトールの替わりに(S)−(−)−1,
1' −ビ−2−ナフトールを用いて調製し、0.1M
(S)−ALBのテトラヒドロフラン溶液として用い
た。
Reference Example 2 Preparation of aluminum-lithium- (S) -binaphthol complex [general formula (1-2)] (hereinafter abbreviated as (S) -ALB) In the operation of Reference Example 1, (R)-( +)-1,1'-
Bi-2-naphthol instead of (S)-(-)-1,
Prepared using 1'-bi-2-naphthol, 0.1M
(S) -ALB was used as a tetrahydrofuran solution.

【0020】実施例1 (R)−2−メチル−1−フェニル−3−ジエチルアミ
ノ−1−プロパノン(化合物番号1)の合成
Example 1 Synthesis of (R) -2-methyl-1-phenyl-3-diethylamino-1-propanone (Compound No. 1)

【化19】 アルゴン雰囲気下、モレキュラーシーブス3A11.1
gに、ランタノイドトリフレート[La(OTf)3
nH2O(n=8−9)]0.54gを加え、0.07
4M(R)−ALBのテトラヒドロフラン溶液10ml
を加えて、減圧下テトラヒドロフランを留去した。トル
エン35mlを加えて、ジエチルアミノメチルメチルエ
ーテル1.07ml(7.4mmol)を加えた。さら
にプロピオフェノン0.98ml(7.4mmol)を
加えて室温にて36時間攪拌した。
Embedded image Molecular sieves 3A11.1 under argon atmosphere
g, lanthanoid triflate [La (OTf) 3.
nH2O (n = 8-9)] 0.54 g, and 0.07 g
4M (R) -ALB solution in tetrahydrofuran 10ml
And tetrahydrofuran was distilled off under reduced pressure. Toluene (35 ml) was added, and diethylaminomethyl methyl ether (1.07 ml, 7.4 mmol) was added. Further, 0.98 ml (7.4 mmol) of propiophenone was added, and the mixture was stirred at room temperature for 36 hours.

【0021】反応懸濁液よりモレキュラーシーブスを濾
去し、5N塩酸30mlで3回抽出し、水層をジエチル
エーテル洗浄した(10ml×2)。水層を冷却しなが
ら5%アンモニア水溶液400mlにて中和し、ジエチ
ルエーテルで抽出した(100ml×3)。有機層を、
飽和食塩水100mlで洗浄し、無水硫酸ナトリウム1
0gで乾燥した。減圧下溶媒を留去して、表題化合物
0.86g(3.9mmol)を得た(収率53%)。
From the reaction suspension, molecular sieves were removed by filtration, extracted with 30 ml of 5N hydrochloric acid three times, and the aqueous layer was washed with diethyl ether (10 ml × 2). The aqueous layer was neutralized with 400 ml of a 5% aqueous ammonia solution while cooling, and extracted with diethyl ether (100 ml × 3). The organic layer
After washing with 100 ml of saturated saline, anhydrous sodium sulfate 1
Dried at 0 g. The solvent was distilled off under reduced pressure to obtain 0.86 g (3.9 mmol) of the title compound (yield 53%).

【0022】1H−NMR(C66,500MHz) :δ0.90(6H,t,J=7.0Hz),1.17
(3H,d,J=6.7Hz),2.37(4H,q,
J=7.0Hz),2.39(1H,dd,J=6.
4,12.8Hz),2.94(1H,dd,J=5.
2,12.8Hz),3.52−3.59(1H,
m,),7.08−8.00(5H,m). 対掌体過剰率:30%ee
1H-NMR (C 6 D 6 , 500 MHz): δ 0.90 (6H, t, J = 7.0 Hz), 1.17
(3H, d, J = 6.7 Hz), 2.37 (4H, q,
J = 7.0 Hz), 2.39 (1H, dd, J = 6.
4,12.8 Hz), 2.94 (1H, dd, J = 5.
2,12.8 Hz), 3.52-3.59 (1H,
m,), 7.08-8.00 (5H, m). Enantiomeric excess: 30% ee

【0023】実施例2 (R)−2−メチル−1−(4−トリフルオロメチルフ
ェニル)−3−ピロリジノ−1−プロパノン 塩酸塩
(化合物番号2)の合成
Example 2 Synthesis of (R) -2-methyl-1- (4-trifluoromethylphenyl) -3-pyrrolidino-1-propanone hydrochloride (Compound No. 2)

【化20】 窒素雰囲気下、モレキュラーシーブス3A16.65g
に、ランタノイドトリフレート〔La(OTf)3・n
H2O(n=8−9)〕0.81gを加え、0.1M
(R)−ALBのテトラヒドロフラン溶液11mlを加
えて、減圧下テトラヒドロフランを留去した。ベンゼン
50mlを加えて、ピロリジノメチルメチルエーテル
1.28g(11.1mmol)を加えた。さらに1−
(4−トリフルオロメチルフェニル)−プロパノン2.
24g(11.1mmol)を加えて室温にて48時間
攪拌した。反応懸濁液よりモレキュラーシーブスを濾去
し、5N塩酸45mlで3回抽出し、水層をジエチルエ
ーテルで洗浄した(15ml×2)。水層を冷却しなが
ら5%アンモニア水溶液600mlにて中和し、ジエチ
ルエーテルで抽出した(150ml×3)。有機層を、
飽和食塩水150mlで洗浄し、無水硫酸ナトリウム1
5gで乾燥した。氷冷下4N塩酸/ジオキサン溶液10
mlを滴下し、室温にて1時間攪拌した。減圧下溶媒を
留去し得られた結晶をジエチルエーテルで洗浄(5ml
×2)、表題化合物3.00g(6.99mmol)を
得た(収率63%)。 1H−NMR(CDCl3,270MHz) :δ1.25(3H,d,J=7.0Hz),1.4−
2.1(4H,m),2.3−3.2(6H,m),
3.65(1H,m),7.70(2H,d,J=8.
0Hz),8.05(2H,d,J=8.0Hz). 対掌体過剰率:40%ee
Embedded image 16.65 g of molecular sieves 3A under a nitrogen atmosphere
Lanthanoid triflate [La (OTf) 3 · n
H2O (n = 8-9)], 0.81 g, and 0.1M
11 ml of a tetrahydrofuran solution of (R) -ALB was added, and tetrahydrofuran was distilled off under reduced pressure. 50 ml of benzene was added, and 1.28 g (11.1 mmol) of pyrrolidinomethyl methyl ether was added. Further 1-
(4-trifluoromethylphenyl) -propanone
24 g (11.1 mmol) was added, and the mixture was stirred at room temperature for 48 hours. The molecular sieves were filtered off from the reaction suspension, extracted with 45 ml of 5N hydrochloric acid three times, and the aqueous layer was washed with diethyl ether (15 ml × 2). The aqueous layer was neutralized with 600 ml of a 5% aqueous ammonia solution while cooling, and extracted with diethyl ether (150 ml × 3). The organic layer
After washing with 150 ml of saturated saline, anhydrous sodium sulfate 1
Dry with 5 g. 4N hydrochloric acid / dioxane solution 10 under ice-cooling
Then, the mixture was stirred at room temperature for 1 hour. The crystals obtained by evaporating the solvent under reduced pressure were washed with diethyl ether (5 ml).
× 2) to obtain 3.00 g (6.99 mmol) of the title compound (yield: 63%). 1H-NMR (CDCl 3 , 270 MHz): δ 1.25 (3H, d, J = 7.0 Hz), 1.4-
2.1 (4H, m), 2.3-3.2 (6H, m),
3.65 (1H, m), 7.70 (2H, d, J = 8.
0 Hz), 8.05 (2H, d, J = 8.0 Hz). Enantiomeric excess: 40% ee

【0024】実施例3 (R)−2−メチル−1−(4−エチルフェニル)−3
−ピぺリジノ−1−プロパノン 塩酸塩(化合物番号
3)の合成
Example 3 (R) -2-methyl-1- (4-ethylphenyl) -3
Synthesis of -piperidino-1-propanone hydrochloride (Compound No. 3)

【化21】 アルゴン雰囲気下、モレキュラーシーブス3A13.3
2gに、ランタノイドトリフレート〔La(OTf)3
・nH2O(n=8−9)〕0.648gを加え、0.
1M(R)−ALBのテトラヒドロフラン溶液9mlを
加えて、減圧下テトラヒドロフランを留去した。トルエ
ン40mlを加えて、ピペリジノメチルメチルエーテル
1.15g(8.9mmol)を加えた。さらに1−
(4−エチルフェニル)−プロパノン1.44g(8.
9mmol)を加えて室温にて28時間攪拌した。
Embedded image Under an argon atmosphere, molecular sieves 3A13.3
2 g of lanthanoid triflate [La (OTf) 3
• nH2O (n = 8-9)], 0.648 g,
9 ml of a 1 M (R) -ALB tetrahydrofuran solution was added, and tetrahydrofuran was distilled off under reduced pressure. 40 ml of toluene was added, and 1.15 g (8.9 mmol) of piperidinomethyl methyl ether was added. Further 1-
1.44 g of (4-ethylphenyl) -propanone (8.
9 mmol) and stirred at room temperature for 28 hours.

【0025】反応懸濁液よりモレキュラーシーブスを濾
去し、5N塩酸36mlで3回抽出し、水層をジクロロ
メタンで洗浄した(12ml×2)。水層を冷却しなが
ら5%アンモニア水溶液480mlにて中和し、ジクロ
ロメタンで抽出した(120ml×3)。有機層を、飽
和食塩水120mlで洗浄し、無水硫酸ナトリウム12
gで乾燥した。氷冷下4N塩酸/ジオキサン溶液10m
lを滴下し、室温にて1時間攪拌した。減圧下溶媒を留
去し得られた結晶をn−ヘキサンで洗浄(5ml×
2)、表題化合物1.42g(4.8mmol)を得た
(収率54%)。 1H−NMR(CDCl3,270MHz) :δ1.13(3H,t,J=7.0Hz),1.27
(3H,d,J=7.0Hz),1.4−2.2(6
H,m),2.3−3.2(6H,m),2.82(2
H,q,J=7.0Hz),3.64(1H,m),
7.70(2H,d,J=8.0Hz),8.05(2
H,d,J=8.0Hz). 対掌体過剰率:35%ee
The molecular sieves were filtered off from the reaction suspension, extracted with 36 ml of 5N hydrochloric acid three times, and the aqueous layer was washed with dichloromethane (12 ml × 2). The aqueous layer was neutralized with 480 ml of a 5% aqueous ammonia solution while cooling, and extracted with dichloromethane (120 ml × 3). The organic layer was washed with 120 ml of saturated saline, and dried over anhydrous sodium sulfate 12 ml.
g. 4N hydrochloric acid / dioxane solution 10m under ice cooling
1 was added dropwise and stirred at room temperature for 1 hour. The crystals obtained by evaporating the solvent under reduced pressure were washed with n-hexane (5 ml ×
2), 1.42 g (4.8 mmol) of the title compound were obtained (54% yield). 1H-NMR (CDCl 3 , 270 MHz): δ 1.13 (3H, t, J = 7.0 Hz), 1.27
(3H, d, J = 7.0 Hz), 1.4-2.2 (6
H, m), 2.3-3.2 (6H, m), 2.82 (2
H, q, J = 7.0 Hz), 3.64 (1H, m),
7.70 (2H, d, J = 8.0 Hz), 8.05 (2
H, d, J = 8.0 Hz). Enantiomeric excess: 35% ee

【0026】実施例4 (R)−2−メチル−1−(4−エチルフェニル)−3
−ピロリジノ−1−プロパノン塩酸塩(化合物番号4)
の合成
Example 4 (R) -2-methyl-1- (4-ethylphenyl) -3
-Pyrrolidino-1-propanone hydrochloride (Compound No. 4)
Synthesis of

【化22】 窒素雰囲気下、モレキュラーシーブス3A11.1g
に、ランタノイドトリフレート〔La(OTf)3・n
H2O(n=8−9)〕0.54gを加え、0.074
M(R)−ALBのテトラヒドロフラン溶液10mlを
加えて、減圧下テトラヒドロフランを留去した。トルエ
ン32.5mlを加えて、ピロリジノメチルメチルエー
テル1.20g(7.4mmol)を加えた。さらに1
−(4−エチルフェニル)−プロパノン0.85g
(7.4mmol)を加えて室温にて36時間攪拌し
た。
Embedded image Under nitrogen atmosphere, molecular sieves 3A 11.1 g
Lanthanoid triflate [La (OTf) 3 · n
H2O (n = 8-9)], 0.54 g, and 0.074 g
10 ml of a tetrahydrofuran solution of M (R) -ALB was added, and tetrahydrofuran was distilled off under reduced pressure. Toluene (32.5 ml) was added, and pyrrolidinomethyl methyl ether (1.20 g, 7.4 mmol) was added. One more
-(4-ethylphenyl) -propanone 0.85 g
(7.4 mmol) was added and the mixture was stirred at room temperature for 36 hours.

【0027】反応懸濁液よりモレキュラーシーブスを濾
去し、5N塩酸30mlで3回抽出し、水層を酢酸エチ
ルで洗浄した(10ml×2)。水層を冷却しながら5
%アンモニア水溶液400mlにて中和し、酢酸エチル
で抽出した(100ml×3)。有機層を、飽和食塩水
100mlで洗浄し、無水硫酸ナトリウム10gで乾燥
した。氷冷下10%塩酸メタノール溶液30mlを滴下
し、室温にて1時間攪拌した。減圧下溶媒を留去し得ら
れた結晶を酢酸エチルで洗浄(5ml×2)、表題化合
物1.06g(3.77mmol)を得た(収率51
%)。 1H−NMR(CDCl3,270MHz) :δ1.12(3H,t,J=7.0Hz),1.27
(3H,d,J=7.0Hz),1.4−2.1(4
H,m),2.3−3.2(6H,m),2.82(2
H,q,J=7.0Hz),3.64(1H,m),
7.71(2H,d,J=8.0Hz),8.05(2
H,d,J=8.0Hz). 対掌体過剰率:33%ee
The molecular sieves were filtered off from the reaction suspension, extracted three times with 30 ml of 5N hydrochloric acid, and the aqueous layer was washed with ethyl acetate (10 ml × 2). 5 while cooling the water layer
The mixture was neutralized with 400% aqueous ammonia and extracted with ethyl acetate (100 ml × 3). The organic layer was washed with 100 ml of saturated saline and dried with 10 g of anhydrous sodium sulfate. Under ice-cooling, 30 ml of a 10% methanolic hydrochloric acid solution was added dropwise, and the mixture was stirred at room temperature for 1 hour. The crystals obtained by evaporating the solvent under reduced pressure were washed with ethyl acetate (5 ml × 2) to obtain 1.06 g (3.77 mmol) of the title compound (yield: 51).
%). 1H-NMR (CDCl 3 , 270 MHz): δ 1.12 (3H, t, J = 7.0 Hz), 1.27
(3H, d, J = 7.0 Hz), 1.4-2.1 (4
H, m), 2.3-3.2 (6H, m), 2.82 (2
H, q, J = 7.0 Hz), 3.64 (1H, m),
7.71 (2H, d, J = 8.0 Hz), 8.05 (2
H, d, J = 8.0 Hz). Enantiomeric excess: 33% ee

【0028】実施例5 (R)−2−メチル−1−(4−メチルフェニル)−3
−ピぺリジノ−1−プロパノン塩酸塩(化合物番号5)
の合成
Example 5 (R) -2-methyl-1- (4-methylphenyl) -3
-Piridino-1-propanone hydrochloride (Compound No. 5)
Synthesis of

【化23】 窒素雰囲気下、モレキュラーシーブス3A11.1g
に、ランタノイドトリフレート〔La(OTf)3・n
H2O(n=8−9)〕0.54gを加え、0.074
M(R)−ALBのテトラヒドロフラン溶液10mlを
加えた。テトラヒドロフラン/ジエチルエーテル=1/
1(v/v)の混合溶媒32.5mlを加えて、ピペリ
ジノメチルメチルエーテル0.96g(7.4mmo
l)を加えた。さらに1−(4−メチルフェニル)−プ
ロパノン1.10g(7.4mmol)を加えて室温に
て36時間攪拌した。
Embedded image Under nitrogen atmosphere, molecular sieves 3A 11.1 g
Lanthanoid triflate [La (OTf) 3 · n
H2O (n = 8-9)], 0.54 g, and 0.074 g
10 ml of a tetrahydrofuran solution of M (R) -ALB was added. Tetrahydrofuran / diethyl ether = 1 /
1 (v / v) of a mixed solvent (32.5 ml) was added, and piperidinomethyl methyl ether (0.96 g, 7.4 mmol) was added.
l) was added. Further, 1.10 g (7.4 mmol) of 1- (4-methylphenyl) -propanone was added, and the mixture was stirred at room temperature for 36 hours.

【0029】反応懸濁液よりモレキュラーシーブスを濾
去し、5N塩酸30mlで3回抽出し、水層をジエチル
エーテルで洗浄した(10ml×2)。水層を冷却しな
がら5%アンモニア水溶液400mlにて中和し、ジエ
チルエーテルで抽出した(100ml×3)。有機層
を、飽和食塩水100mlで洗浄し、無水硫酸ナトリウ
ム10gで乾燥した。氷冷下4N塩酸/ジオキサン溶液
10mlを滴下し、室温にて1時間攪拌した。減圧下溶
媒を留去し得られた結晶をジエチルエーテルで洗浄(5
ml×2)、表題化合物1.18g(4.2mmol)
を得た(収率57%)。 1H−NMR(CDCl3,270MHz) :δ1.27(3H,d,J=7.0Hz),1.4−
2.2(6H,m),2.27(3H,s),2.3−
3.2(6H,m),3.55(1H,m),7.70
(2H,d,J=8.0Hz),8.05(2H,d,
J=8.0Hz). 対掌体過剰率:35%ee
The molecular sieves were filtered off from the reaction suspension, extracted three times with 30 ml of 5N hydrochloric acid, and the aqueous layer was washed with diethyl ether (10 ml × 2). The aqueous layer was neutralized with 400 ml of a 5% aqueous ammonia solution while cooling, and extracted with diethyl ether (100 ml × 3). The organic layer was washed with 100 ml of saturated saline and dried with 10 g of anhydrous sodium sulfate. Under ice cooling, 10 ml of a 4N hydrochloric acid / dioxane solution was added dropwise, and the mixture was stirred at room temperature for 1 hour. The crystals obtained by evaporating the solvent under reduced pressure were washed with diethyl ether (5.
ml × 2), 1.18 g (4.2 mmol) of the title compound
Was obtained (yield 57%). 1H-NMR (CDCl 3 , 270 MHz): δ 1.27 (3H, d, J = 7.0 Hz), 1.4-
2.2 (6H, m), 2.27 (3H, s), 2.3-
3.2 (6H, m), 3.55 (1H, m), 7.70
(2H, d, J = 8.0 Hz), 8.05 (2H, d,
J = 8.0 Hz). Enantiomeric excess: 35% ee

【0030】実施例6〜10 以下、実施例6−10は実施例2と同様の操作を行い、
化合物番号6−10を製造した(表1)。
Examples 6 to 10 Hereinafter, in Examples 6 to 10, the same operation as in Example 2 was performed.
Compound Nos. 6-10 were prepared (Table 1).

【表1】 [Table 1]

【0031】実施例11 (R)−3−フェニル−5−{2−(ピロリジニルメチ
ル)ブチリル}イソオキサゾール塩酸塩(化合物番号1
1)の合成
Example 11 (R) -3-phenyl-5- {2- (pyrrolidinylmethyl) butyryl} isoxazole hydrochloride (Compound No. 1)
Synthesis of 1)

【化24】 窒素雰囲気下、モレキュラーシーブス3A25.0g
に、ランタノイドトリフレート La(OTf)3・n
H2O(n=8−9) 1.62gを加え、0.1M
(R)−ALBのテトラヒドロフラン溶液22.2ml
を加えて、減圧下テトラヒドロフランを留去した。トル
エン100mlを加えて、ピロリジノメチルメチルエー
テル2.56g(22.2mmol)を加えた。さらに
3−フェニル−5−ブチリルイソオキサゾール4.78
g(22.2mmol)を加えて室温にて36時間攪拌
した。
Embedded image Under a nitrogen atmosphere, molecular sieves 3A 25.0 g
Lanthanoid triflate La (OTf) 3 · n
Add 1.62 g of H2O (n = 8-9), add 0.1M
22.2 ml of a tetrahydrofuran solution of (R) -ALB
And tetrahydrofuran was distilled off under reduced pressure. 100 ml of toluene was added, and 2.56 g (22.2 mmol) of pyrrolidinomethyl methyl ether was added. Further, 3.78 3-phenyl-5-butyryl isoxazole
g (22.2 mmol) was added and stirred at room temperature for 36 hours.

【0032】反応懸濁液よりモレキュラーシーブスを濾
去し、5N塩酸50mlで3回抽出し、水層を酢酸エチ
ルで洗浄した(30ml×2)。水層を冷却しながら5
%アンモニア水溶液700mlにて中和し、ジクロロメ
タンで抽出した(300ml×3)。有機層を、飽和食
塩水200mlで洗浄し、減圧下溶媒を留去して得られ
た粗生成物をジクロロメタン10mlに溶解し、氷冷下
10%塩酸水溶液10mlを滴下し、室温にて1時間攪
拌した。分液後、有機層を無水硫酸ナトリウム20gで
乾燥し、酢酸エチル20mlを加えて5℃にて1時間攪
拌後、結晶を濾取し、酢酸エチルで洗浄して(5ml×
2)、表題化合物3.12g(9.32mmol)を得
た(収率82%)。 1H−NMR(CDCl3,270MHz) :δ0.99(3H,t,J=7.3Hz),1.77
−1.83(1H,m),1.88−1.97(1H,
m),1.98−2.11(2H,m),2.11−
2.23(2H,m),2.70−2.78(1H,
m),2.79−2.95(1H,m),3.33(1
H,m),3.47−3.64(1H,m),3.68
−3.71(1H,m),3.83−3.87(1H,
m),4.33−4.38(1H,m),7.48−
7.50(3H,m),7.76(1H,s),7.8
7−7.90(2H,m). 対掌体過剰率:42%ee
The molecular sieves were filtered off from the reaction suspension, extracted three times with 50 ml of 5N hydrochloric acid, and the aqueous layer was washed with ethyl acetate (30 ml × 2). 5 while cooling the water layer
The mixture was neutralized with 700 ml of an aqueous ammonia solution and extracted with dichloromethane (300 ml × 3). The organic layer was washed with 200 ml of saturated saline, and the crude product obtained by evaporating the solvent under reduced pressure was dissolved in 10 ml of dichloromethane, and 10 ml of a 10% aqueous hydrochloric acid solution was added dropwise under ice-cooling, and the mixture was stirred at room temperature for 1 hour. Stirred. After liquid separation, the organic layer was dried over anhydrous sodium sulfate (20 g), ethyl acetate (20 ml) was added, and the mixture was stirred at 5 ° C for 1 hour. The crystals were collected by filtration, washed with ethyl acetate (5 ml ×
2), 3.12 g (9.32 mmol) of the title compound were obtained (82% yield). 1H-NMR (CDCl 3 , 270 MHz): δ 0.99 (3H, t, J = 7.3 Hz), 1.77
-1.83 (1H, m), 1.88-1.97 (1H,
m), 1.98-2.11 (2H, m), 2.11
2.23 (2H, m), 2.70-2.78 (1H,
m), 2.79-2.95 (1H, m), 3.33 (1
H, m), 3.47-3.64 (1H, m), 3.68
-3.71 (1H, m), 3.83-3.87 (1H,
m), 4.33-4.38 (1H, m), 7.48-
7.50 (3H, m), 7.76 (1H, s), 7.8
7-7.90 (2H, m). Enantiomeric excess: 42% ee

【0033】実施例12 (S)−3−フェニル−5−{2−(ピぺリジニルメチ
ル)プロピオニル}イソオキサゾール塩酸塩(化合物番
号12)の合成
Example 12 Synthesis of (S) -3-phenyl-5- {2- (piridinylmethyl) propionyl} isoxazole hydrochloride (Compound No. 12)

【化25】 窒素雰囲気下、モレキュラーシーブス3A30.0g
に、ランタノイドトリフレート La(OTf)3・n
H2O(n=8−9) 1.62gを加え、0.1M
(S)−ALBのテトラヒドロフラン溶液22.2ml
を加えて、減圧下テトラヒドロフランを留去した。トル
エン100mlを加えて、ピぺリジノメチルメチルエー
テル2.87g(22.2mmol)を加えた。さらに
3−フェニル−5−プロピオニルイソオキサゾール4.
47g(22.2mmol)を加えて室温にて28時間
攪拌した。
Embedded image Under nitrogen atmosphere, molecular sieves 3A30.0g
Lanthanoid triflate La (OTf) 3 · n
Add 1.62 g of H2O (n = 8-9), add 0.1M
22.2 ml of a tetrahydrofuran solution of (S) -ALB
And tetrahydrofuran was distilled off under reduced pressure. 100 ml of toluene was added, and 2.87 g (22.2 mmol) of piperidinomethyl methyl ether was added. 3. 3-phenyl-5-propionyl isoxazole;
47 g (22.2 mmol) was added and the mixture was stirred at room temperature for 28 hours.

【0034】反応懸濁液よりモレキュラーシーブスを濾
去し、5N塩酸50mlで3回抽出し、水層を酢酸エチ
ルで洗浄した(30ml×2)。水層を冷却しながら5
%アンモニア水溶液700mlにて中和し、ジクロロメ
タンで抽出した(300ml×3)。有機層を、飽和食
塩水200mlで洗浄し、無水硫酸ナトリウム20gで
乾燥し、減圧下溶媒を留去して表題化合物4.11g
(13.76mmol)を白色結晶として得た(収率6
2%)。 融点 114−116℃ 1H−NMR(CDCl3,270MHz) :δ1.3(3H,d,J=6Hz),1.5−1.8
(6H,m),2.3−3.0(6H,m),3.5−
4.0(1H,m),7.2(1H,s),7.5−
7.7(3H,m),7.7−8.0(2H,m). 対掌体過剰率:30%ee
The molecular sieves were filtered off from the reaction suspension, extracted three times with 50 ml of 5N hydrochloric acid, and the aqueous layer was washed with ethyl acetate (30 ml × 2). 5 while cooling the water layer
The mixture was neutralized with 700 ml of an aqueous ammonia solution and extracted with dichloromethane (300 ml × 3). The organic layer was washed with saturated saline (200 ml), dried over anhydrous sodium sulfate (20 g), and the solvent was distilled off under reduced pressure to give the title compound (4.11 g).
(13.76 mmol) as white crystals (yield 6).
2%). Melting point 114-116 ° C 1H-NMR (CDCl 3 , 270 MHz): δ1.3 (3H, d, J = 6 Hz), 1.5-1.8.
(6H, m), 2.3-3.0 (6H, m), 3.5-
4.0 (1H, m), 7.2 (1H, s), 7.5-
7.7 (3H, m), 7.7-8.0 (2H, m). Enantiomeric excess: 30% ee

【0035】実施例13〜18 以下、実施例13−18は実施例11と同様の操作を行
い、化合物番号13−18を製造した(表2)。
Examples 13 to 18 The same procedures as in Example 11 were carried out in Examples 13 to 18 to produce Compound Nos. 13 to 18 (Table 2).

【表2】 [Table 2]

【0036】[0036]

【発明の効果】本発明は、医薬品として有用な、中枢性
筋弛緩作用を有するα−置換−β−アミノケトン誘導体
の光学活性体を、多機能複合金属錯体である光学活性ラ
ンタン−アルカリ金属−ビナフトール錯体を触媒として
使用するα−アミノエーテルを用いた不斉マンニッヒ反
応により、光学不活性な出発原料から一工程で直接的に
製造する、効果的な方法である。本発明の方法は、公知
の方法のようにラセミ体を合成した後、光学分割により
不要な光学異性体を除去する必要がなく工業的に優れた
方法である。
Industrial Applicability The present invention relates to an optically active α-substituted-β-aminoketone derivative having a central muscle relaxing action, which is useful as a pharmaceutical, and an optically active lanthanum-alkali metal-binaphthol which is a multifunctional complex metal complex. This is an effective method in which an asymmetric Mannich reaction using an α-amino ether using a complex as a catalyst is directly performed in one step from optically inactive starting materials. The method of the present invention is industrially excellent because it is not necessary to remove unnecessary optical isomers by optical resolution after synthesizing a racemate as in a known method.

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.7 識別記号 FI テーマコート゛(参考) C07D 275/02 C07D 275/02 275/03 295/10 Z 295/10 C07B 61/00 300 // C07B 61/00 300 C07M 7:00 (72)発明者 荒井 孝義 大阪府箕面市粟生新家3−4−25 サニー コート(I)102 (72)発明者 柴崎 正勝 東京都三鷹市下連雀2丁目11番2号 Fターム(参考) 4C033 AA04 AA05 AA18 4C056 AA01 AB01 AC01 AD01 AE03 AF10 FA04 FA13 FB01 FC01 4G069 AA06 BA27A BA27B BA44A BC04A BC04B BC16A BC16B BC39A BC40A BC42A BD02A BD02B BD08A BD08B BD15A BD15B BE02A BE02B BE37A BE37B CB57 4H006 AA02 AC25 AC81 BA02 BA08 BA09 BA36 BA45 BA67 BA71 BJ50 BR30 BU32 4H039 CA19 CD10 CD40 ──────────────────────────────────────────────────の Continued on the front page (51) Int.Cl. 7 Identification code FI Theme coat ゛ (Reference) C07D 275/02 C07D 275/02 275/03 295/10 Z 295/10 C07B 61/00 300 // C07B 61 / 00 300 C07M 7:00 (72) Inventor Takayoshi Arai 3-4-25 Aow Shinke, Minoh-shi, Osaka Sunny Court (I) 102 (72) Inventor Masakatsu Shibasaki 2-1-21-2 Shimorenjaku, Mitaka-shi, Tokyo F Term (reference) 4C033 AA04 AA05 AA18 4C056 AA01 AB01 AC01 AD01 AE03 AF10 FA04 FA13 FB01 FC01 4G069 AA06 BA27A BA27B BA44A BC04A BC04B BC16A BC16B BC39A BC40A BC42A BD02A BD02B BD08A BE08B BAA BDA BA45 BA67 BA71 BJ50 BR30 BU32 4H039 CA19 CD10 CD40

Claims (5)

【特許請求の範囲】[Claims] 【請求項1】 光学活性アルミニウム−アルカリ金属−
ビナフトール錯体、ルイス酸及びα−アミノエーテル誘
導体を用いて不斉マンニッヒ反応を行う、光学活性α−
置換−β−アミノケトン誘導体の製造法。
1. An optically active aluminum-alkali metal-
Performing an asymmetric Mannich reaction using a binaphthol complex, a Lewis acid, and an α-aminoether derivative, an optically active α-
A method for producing a substituted-β-aminoketone derivative.
【請求項2】 光学活性アルミニウム−アルカリ金属−
ビナフトール錯体が、一般式(1)〔一般式(1−1)
及び(1−2)〕: 【化1】 で表される化合物である請求項1記載の製造法。
2. An optically active aluminum-alkali metal-
The binaphthol complex is represented by the general formula (1) [general formula (1-1)
And (1-2)]: The method according to claim 1, which is a compound represented by the formula:
【請求項3】ルイス酸が、一般式(2): 【化2】 (式中、Mはランタン原子、イッテルビウム原子または
スカンジウム原子を表し、mは正の整数である)で表さ
れる化合物である請求項1または2記載の製造法。
3. A Lewis acid having the general formula (2): The method according to claim 1, wherein the compound is a compound represented by the formula: wherein M represents a lanthanum atom, a ytterbium atom or a scandium atom, and m is a positive integer.
【請求項4】α−アミノエーテル誘導体が、一般式
(3) 【化3】 〔式中、R1は低級アルキル基、フェニル基またはベン
ジル基、R2及びR3は独立に飽和もしくは不飽和の低
級アルキル基を表すか、R2とR3がひとつになって一
般式(4) 【化4】 (式中、nは0または1〜2の整数であり、Zは酸素原
子、メチレン基、アミノ基、メチルアミノ基、ベンジル
アミノ基を表す。)を表す。〕で表される化合物である
請求項1乃至3記載の製造法。
4. An α-amino ether derivative represented by the following general formula (3): [Wherein, R1 represents a lower alkyl group, a phenyl group or a benzyl group, R2 and R3 independently represent a saturated or unsaturated lower alkyl group, or R2 and R3 become one to form a general formula (4) ] (In the formula, n is 0 or an integer of 1 to 2, and Z represents an oxygen atom, a methylene group, an amino group, a methylamino group, or a benzylamino group.) The method according to any one of claims 1 to 3, which is a compound represented by the formula:
【請求項5】 光学活性α−置換−β−アミノケトン誘
導体が、一般式(5) 【化5】 {式中、R4は、一般式(6)〔一般式(6−1)及び
(6−2)〕: 【化6】 (R6は、ハロゲン原子;低級アルキル基;ベンジル
基;ベンゾイル基;ピリジル基;低級アルキル基で置換
されてもよいフリル基;低級アルキル基で置換されても
よいチエニル基;ハロゲン原子、低級アルコキシ基、ト
リフルオロメチル基、シアノ基、ニトロ基、アミノ基、
ジメチルアミノ基、アセトアミド基、メタンスルホニル
アミド基、アセチル基または低級アルコキシカルボニル
基で置換されていてもよいフェニル基またはナフチル基
を:R7はトリフルオロメチル基、低級アルキル基を;
Yは酸素原子または硫黄原子を表す)を表し、R2は低
級アルキル基;ベンジル基;メトキシ基;フェニル基;
アリル基;トリフルオロメチル基または低級アルコキシ
基で置換されたアルキル基;またはシクロプロピルメチ
ル基を、R3及びR4は独立に飽和もしくは不飽和の低
級アルキル基を表すか、R3とR4がひとつになって一
般式(4): 【化7】 (式中、nは0、または1〜2の整数を表し、Zはメチ
レン基、酸素原子、アミノ基、メチルアミノ基、ベンジ
ルアミノ基を表す。)を表す。}である請求項1乃至4
に記載の製造方法。
5. An optically active α-substituted-β-aminoketone derivative represented by the following general formula (5): In the formula, R4 is a group represented by the general formula (6) [general formulas (6-1) and (6-2)]: (R6 is a halogen atom; a lower alkyl group; a benzyl group; a benzoyl group; a pyridyl group; a furyl group optionally substituted with a lower alkyl group; a thienyl group optionally substituted with a lower alkyl group; a halogen atom, a lower alkoxy group , Trifluoromethyl group, cyano group, nitro group, amino group,
A phenyl group or a naphthyl group optionally substituted with a dimethylamino group, an acetamido group, a methanesulfonylamido group, an acetyl group or a lower alkoxycarbonyl group: R7 represents a trifluoromethyl group or a lower alkyl group;
Y represents an oxygen atom or a sulfur atom), and R2 represents a lower alkyl group; a benzyl group; a methoxy group; a phenyl group;
An allyl group; an alkyl group substituted with a trifluoromethyl group or a lower alkoxy group; or a cyclopropylmethyl group, R3 and R4 each independently represent a saturated or unsaturated lower alkyl group, or R3 and R4 become one And the general formula (4): (In the formula, n represents 0 or an integer of 1 to 2, and Z represents a methylene group, an oxygen atom, an amino group, a methylamino group, or a benzylamino group.) }
The production method described in 1.
JP10238064A 1998-08-25 1998-08-25 Production of optically active alpha-substituted-beta- aminoketone derivative Pending JP2000072728A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP10238064A JP2000072728A (en) 1998-08-25 1998-08-25 Production of optically active alpha-substituted-beta- aminoketone derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10238064A JP2000072728A (en) 1998-08-25 1998-08-25 Production of optically active alpha-substituted-beta- aminoketone derivative

Publications (1)

Publication Number Publication Date
JP2000072728A true JP2000072728A (en) 2000-03-07

Family

ID=17024627

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10238064A Pending JP2000072728A (en) 1998-08-25 1998-08-25 Production of optically active alpha-substituted-beta- aminoketone derivative

Country Status (1)

Country Link
JP (1) JP2000072728A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1623971A1 (en) * 2003-04-25 2006-02-08 Toagosei Co., Ltd. Asymmetric-synthesis catalyst based on chiral broensted acid and method of asymmetric synthesis with the catalyst
JP2009023989A (en) * 2007-07-20 2009-02-05 Ewha Womans Univ Industry Collaboration Foundation Binaphthol derivative and optical resolution and conversion methods
JP2011111426A (en) * 2009-11-29 2011-06-09 Chiba Univ Method for producing bisimidazolidine ligand and catalyst using the same

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1623971A1 (en) * 2003-04-25 2006-02-08 Toagosei Co., Ltd. Asymmetric-synthesis catalyst based on chiral broensted acid and method of asymmetric synthesis with the catalyst
EP1623971A4 (en) * 2003-04-25 2006-11-08 Toagosei Co Ltd Asymmetric-synthesis catalyst based on chiral broensted acid and method of asymmetric synthesis with the catalyst
JP2009023989A (en) * 2007-07-20 2009-02-05 Ewha Womans Univ Industry Collaboration Foundation Binaphthol derivative and optical resolution and conversion methods
JP2011111426A (en) * 2009-11-29 2011-06-09 Chiba Univ Method for producing bisimidazolidine ligand and catalyst using the same

Similar Documents

Publication Publication Date Title
JP4502293B2 (en) Optically active quaternary ammonium salt having axial asymmetry, its production method and application to asymmetric synthesis of α-amino acid derivatives
JPH0137391B2 (en)
Hu et al. Organocatalytic enantioselective sulfa-Michael addition of thiocarboxylic acids to β-trifluoromethyl-α, β-unsaturated ketones for the construction of stereogenic carbon center bearing a sulfur atom and a trifluoromethyl group
KR102261108B1 (en) Highly enantioselective bifunctional chiral organocatalytic compound, method for preparing the same, and method for preparing non-natural gamma-amino acid from nitrocompound using thereof
CN109456253B (en) Method for synthesizing (S) -3- (4-bromophenyl) -piperidine or salt thereof through chiral induction
JP2000072728A (en) Production of optically active alpha-substituted-beta- aminoketone derivative
CN114671825B (en) Synthesis method of chiral 4H-3, 1-benzoxazine compound containing selenoaryl
WO2007045405A1 (en) Process for the preparation of duloxetine
CA2798815C (en) Novel process for the preparation of nitrogen substituted aminotetralins derivatives
WO2011019066A1 (en) Method for producing optically active 1-amino-2-vinylcyclopropanecarboxylic acid ester
JP2000072727A (en) Production of optically active alpha-substituted-bete- aminoketone derivative
JP2005023055A (en) New optically active amine
JP2010508334A (en) Aminobenzocycloheptene derivatives, methods for their preparation and their use in therapy
EP2125772B1 (en) A process for the preparation of duloxetin and new key intermediates for use therein
JPH0720917B2 (en) Nitrogen-containing perfluorocarboxylic acid optically active substance and method for producing the same
US7385080B2 (en) Method for producing optically active β-phenylalanine compounds
JP2002371060A (en) Method for producing optically active aminopiperidine derivative
JPH10237013A (en) Production of optically active 2-benzylsuccinic acid
JP2005104895A (en) Method for preparing optically active amino alcohol compound
JPS58216146A (en) Preparation of optical active-threo-3-(3,4- dihydroxyphenyl)serine
JP3796964B2 (en) Method for producing 4-nitroester compound
JP2002512210A (en) Method for producing 2-hydroxyalkylhalophenone
JP2002080444A (en) New optically active compound and method for producing the same
AU2005273649B2 (en) Enantioselective synthesis of 13-oxotricyclo[8.2.1.0 3,8]trideca-3(8),4,6-triene-5-carboxylates
JP2002522533A (en) Enantioselective synthesis